FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in DACH

Biotech startups in DACH

Updated 16 Nov 2026

Reset
Biotech startups in DACH
One-time CSV
  • 523 funded companies, 304 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~dach.csv523 rows × 18 columns
CompanyCityLast roundAmountDate
Adaptyv BiosystemsLausanneSeries A$40.0M2026-08-25
TubulisMunichSeries C$400.6M2025-10-15
ExcivaHeidelbergSeries B$59.4M2026-01-20
Vaderis TherapeuticsBaselSeries B$152.0M2026-08-11
Seamless TherapeuticsDresdenSeed$12.6M2024-04-23
NVision Quantum TechnologiesUlmSeries B$38.0M2026-05-13
Windward BioBaselSeries B$165.0M2026-05-04
OrbemMunichSeries B$64.6M2026-01-20

8 rows of the CSV in 5 of its 18 columns.

523
Startups
$6.9B
Total raised
68
Funded in the last 12 months
$1.1B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 523
30 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Cellbox Solutions Cellbox Solutions provides logistics solutions for the global biomedical industry. Biotech Cologne, Germany Series A $1.7M 2026-10-20 $15.3M European Innovation Council, Fraunhofer Venture, CK Venture Capital 11 to 50 2017
NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren, Switzerland Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
Adaptyv Biosystems Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. Artificial intelligence Lausanne, Switzerland Series A $40.0M 2026-08-25 $50.9M Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 11 to 50 2020
Computomics Computomics applies artificial intelligence to genomics data to advance agricultural solutions. Artificial intelligence Tübingen, Germany Series B $7.3M 2026-08-18 $10.0M HTGF (High-Tech Gruenderfonds), VentureOut, European Innovation Council +2 11 to 50 2012
Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
smartbax Smartbax develops multi-targeted antibacterial compounds that are potent against multi-drug resistant bacteria. Biotech Munich, Germany Seed $5.5M 2026-06-30 $7.5M HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund 1 to 10 2021
Graph Therapeutics Graph Therapeutics uses AI and multi-omics analysis of patient cells to develop precision immunology treatments. Artificial intelligence Klosterneuburg, Austria Seed $5.0M 2026-06-22 $9.4M SquareOne Venture Capital, Merantix Capital 1 to 10 2024
NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm, Germany Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
Tacalyx Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. Biotech Berlin, Germany Seed $12.9M 2026-04-29 $28.0M HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 1 to 10 2019
mbiomics mbiomics is a biotechnology company. Biotech Munich, Germany Series A $12.0M 2026-04-28 $26.1M HTGF (High-Tech Gruenderfonds), Bayern Kapital, MIG Capital 11 to 50 2020
Omegga GmbH Omegga GmbH develops in-ovo sexing technology that identifies male chicks before hatching to prevent their killing. Artificial intelligence Munich, Germany Seed $11.7M 2026-04-24 $11.7M EIC Accelerator, GETTY 1 to 10 2022
Cellbricks Therapeutics Cellbricks Therapeutics is a biotech company developing methods for replacing tissue and organs. Biotech Berlin, Germany Seed $8.1M 2026-03-25 $11.6M b.value AG, Brooks Hill Partners 11 to 50 2016
Kupando Kupando is a biopharmaceutical company developing agonists that stimulate innate immunity. Biotech Schönefeld, Germany Series A $11.5M 2026-03-18 $24.0M HTGF (High-Tech Gruenderfonds), Brandenburg Kapital, Remiges Ventures +2 1 to 10 2018
Alithea Genomics Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. Biotech Lausanne, Switzerland Seed $3.8M 2026-03-04 $9.9M Foundation for Innovation and Technology (FIT), TechU Ventures, Eurostars +1 11 to 50 2020
Leman Biotech Leman Biotech develops cancer immunotherapies as a biotech company. Biotech Lausanne, Switzerland Series A $28.8M 2026-01-26 $46.8M Tiantu Capital, Fuho Capital 11 to 50 2021
Innocent Meat Innocent Meat provides plug-and-play technology that converts meat producers into cell-based producers. Biotech Rostock, Germany Seed $7.1M 2026-01-22 $11.0M Big Idea Ventures, GENIUS Venture Capital 1 to 10 2020
Orbem Orbem provides AI-powered imaging and analytics for non-invasive biological insights. Artificial intelligence Munich, Germany Series B $64.6M 2026-01-20 $106.5M European Innovation Council, Possible Ventures, 83North +1 101 to 250 2019
Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
FluoSphera FluoSphera develops drugs. Biotech Geneva, Switzerland Seed $1.4M 2026-01-12 $3.9M SOSV, SOSV SF & NY (Fka IndieBio), FONGIT Innovation Fund +2 1 to 10 2021
FoRx Therapeutics FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. Biotech Basel, Switzerland Series A $50.0M 2025-12-18 $109.4M EQT Life Sciences, Novartis Venture Fund, Omega Funds +2 11 to 50 2019
Genknowme Genknowme is a precision health company advancing epigenetics to support personalized and preventive care. Biotech Lausanne, Switzerland Pre-seed $630K 2025-12-18 $947K Venture Kick, Foundation for Innovation and Technology (FIT) 1 to 10 2019
4TEEN4 Pharmaceuticals 4TEEN4 Pharmaceuticals develops therapies and biomarkers for diagnosing, predicting, and treating circulatory shock. Biotech Hennigsdorf, Germany Series C $36.1M 2025-11-13 $95.9M Wellington Partners, Brandenburg Kapital, HBM Healthcare Investments +1 11 to 50 2013
Tubulis Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications. Biotech Munich, Germany Series C $400.6M 2025-10-15 $616.9M HTGF (High-Tech Gruenderfonds), Bayern Kapital, Seventure Partners +1 51 to 100 2012
Hemostod HemostOD manufactures platelets on demand from engineered stem cells. Biotech Lausanne, Switzerland Seed $5.4M 2025-10-01 $7.8M Foundation for Innovation and Technology (FIT) 11 to 50 2020
Cutiss Cutiss is a life science company that produces regenerative medicine and engineers skin tissue. Biotech Zürich, Switzerland Series C $38.8M 2025-09-10 $94.6M Innosuisse 11 to 50 2017
Comphya Comphya develops an active implantable medical device to restore erectile function in patients who do not respond to oral drugs. Biotech Lausanne, Switzerland Series A $4.0M 2025-07-08 $14.2M Venture Kick, Verve Ventures, Nest Collective Foundation 1 to 10 2017
Adiposs Adiposs SA is a clinical-stage life science company developing a first-in-class imaging product for cancer patients. Biotech Geneva, Switzerland Series A $5.0M 2025-06-30 $7.4M MassChallenge, Venture Kick, FONGIT Innovation Fund +2 1 to 10 2020
GlycoEra GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. Biotech Wädenswil, Switzerland Series B $130.0M 2025-05-27 $179.3M Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 11 to 50 2020
Clinomic Clinomic is a medical AI company focused on critical care. Artificial intelligence Aachen, Germany Series B $25.3M 2025-04-08 $54.6M German Federal Ministry of Research, Technology and Space 51 to 100 2019

Table 1. Biotech startups in DACH: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 523.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
1 Windward Bio Windward Bio develops monoclonal antibodies for advanced immunological diseases. Biotech Basel, Switzerland Series B $165.0M 2026-05-04 $365.0M Qiming Venture Partners, OrbiMed, Novo Holdings +2 11 to 50 2024
2 Vaderis Therapeutics Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. Biotech Basel, Switzerland Series B $152.0M 2026-08-11 $170.6M Medicxi 11 to 50 2019
3 Orbem Orbem provides AI-powered imaging and analytics for non-invasive biological insights. Artificial intelligence Munich, Germany Series B $64.6M 2026-01-20 $106.5M European Innovation Council, Possible Ventures, 83North +1 101 to 250 2019
4 Exciva Exciva develops clinical-stage biopharmaceutical therapies for neuropsychiatric symptoms of dementia. Biotech Heidelberg, Germany Series B $59.4M 2026-01-20 $69.8M Andera Partners, LBBW VC, Cure8 Ventures 1 to 10 2015
5 FoRx Therapeutics FoRx Therapeutics is a biotechnology company developing cancer drugs that target DNA replication stress pathways. Biotech Basel, Switzerland Series A $50.0M 2025-12-18 $109.4M EQT Life Sciences, Novartis Venture Fund, Omega Funds +2 11 to 50 2019
6 Adaptyv Biosystems Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. Artificial intelligence Lausanne, Switzerland Series A $40.0M 2026-08-25 $50.9M Y Combinator, Venture Kick, Acequia Capital (AceCap) +2 11 to 50 2020
7 NVision Quantum Technologies NVision Quantum Technologies develops quantum-based imaging technology that enhances standard MRI systems. Biotech Ulm, Germany Series B $38.0M 2026-05-13 $155.2M Entrée Capital, European Commission, Playground Global +2 101 to 250 2015
8 NovaGo Therapeutics NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. Biotech Schlieren, Switzerland Series B $29.7M 2026-08-31 $39.7M Kinled Holding, Pureos Bioventures 1 to 10 2015
9 Leman Biotech Leman Biotech develops cancer immunotherapies as a biotech company. Biotech Lausanne, Switzerland Series A $28.8M 2026-01-26 $46.8M Tiantu Capital, Fuho Capital 11 to 50 2021
10 Tacalyx Tacalyx develops cancer therapies that target tumor-associated carbohydrate antigens. Biotech Berlin, Germany Seed $12.9M 2026-04-29 $28.0M HTGF (High-Tech Gruenderfonds), coparion, Kurma Partners +2 1 to 10 2019

Table 2. Biotech startups in DACH: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 HTGF (High-Tech Gruenderfonds) Venture capital firm Bonn, Germany 77 15% 5 Computomics, smartbax, Tacalyx
2 Venture Kick Startup incubator Schlieren, Switzerland 46 9% 2 Adaptyv Biosystems, Genknowme
3 KfW Government investment office Frankfurt, Germany 21 4%
4 Bayern Kapital Venture capital firm Landshut, Germany 13 2% 1 mbiomics
5 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 11 2% 1 FoRx Therapeutics
6 Novartis Venture Fund Corporate venture arm Basel, Switzerland 11 2% 1 FoRx Therapeutics
7 BioMedPartners Venture capital firm Basel, Switzerland 11 2%
8 Foundation for Innovation and Technology (FIT) Entrepreneurship program Lausanne, Switzerland 10 2% 3 Adaptyv Biosystems, Alithea Genomics, Genknowme
9 Andera Partners Private equity firm Paris, France 10 2% 1 Exciva
10 European Innovation Council Startup accelerator Brussels, Belgium 9 2% 3 Cellbox Solutions, Computomics, Orbem
11 Innosuisse Government investment office Berne, Switzerland 9 2%
12 Boehringer Ingelheim Venture Fund Corporate venture arm Ingelheim Am Rhein, Germany 9 2% 2 smartbax, Tacalyx
13 Wellington Partners Venture capital firm Munich, Germany 7 1%
14 Novo Holdings Corporate venture arm Hellerup, Denmark 7 1% 1 Windward Bio
15 VI Partners Venture capital firm Altendorf, Switzerland 7 1%

Table 3. Biotech startups in DACH: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 384 73% $6.3B
Software 79 15% $369.5M
Artificial intelligence 45 9% $302.9M
Hardware 20 4% $136.5M
Fintech 6 1% $23.6M
Education 6 1% $3.6M
Cybersecurity 2 0% $4.7M
Energy 2 0% $655K
Commerce 2 0% $4.7M

Table 4. Biotech startups in DACH by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 59 11% $586K
Seed 216 41% $2.6M
Series A 130 25% $8.9M
Series B 67 13% $21.4M
Series C 35 7% $13.5M
Series D+ 16 3% $13.8M

Table 5. Biotech startups in DACH by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
Germany 265 51%
Switzerland 207 40%
Austria 50 10%
Liechtenstein 1 0%

Table 6. Biotech startups in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Berlin 48 9%
Basel 39 7%
Lausanne 29 6%
Munich 26 5%
Zürich 25 5%
Vienna 23 4%
Geneva 21 4%
Schlieren 20 4%
Heidelberg 13 2%
Hamburg 13 2%
Cologne 10 2%
Epalinges 10 2%

Table 7. Biotech startups in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 2 3% $35.3M
October 2026 4 6% $141.2M
September 2026 10 15% $23.7M
August 2026 6 9% $236.0M
July 2026 1 1% $2.8M
June 2026 6 9% $60.6M
May 2026 5 7% $210.2M
April 2026 10 15% $64.9M
March 2026 7 10% $45.1M
February 2026 2 3% $873K
January 2026 9 13% $176.4M
December 2025 5 7% $82.1M
November 2025 1 1%

Table 8. Biotech startups in DACH: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 62 12% $997.1M
2025 52 10% $1.1B
2024 66 13% $1.3B
2023 32 6% $268.8M
2022 45 9% $374.3M
2021 37 7% $605.0M

Table 9. Biotech startups in DACH by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 56 11%
2020 to 2022 101 19%
2015 to 2019 163 31%
2010 to 2014 89 17%
Before 2010 110 21%

Table 10. Biotech startups in DACH by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 263 51%
11 to 50 207 40%
51 to 100 31 6%
101 to 250 10 2%
251 to 500 2 0%
501 to 1,000 2 0%
1,001 to 5,000 3 1%
10,001 or more 1 0%

Table 11. Biotech startups in DACH by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in DACH are on the list?
523, in the file dated 16 November 2026. 68 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 523 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $349.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in DACH: 523 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $349 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in DACH by funding stage

Other sectors in DACH

Biotech startups elsewhere

Cite: FundingWatcher, 523 funded biotech companies in DACH, 16 November 2026. https://fundingwatcher.com/startups/biotech/dach/